Skip to main content

Table 3 Pharmacokinetic model parameters for plasma tulathromycin and milk CP-60,300 concentrations in lactating goats

From: Estimation of tulathromycin depletion in plasma and milk after subcutaneous injection in lactating goats using a nonlinear mixed-effects pharmacokinetic modeling approach

Parameter

Description

Population mean

IIV

Bootstrap value

2.5% CI

97.5% CI

V (mL)

Volume of distribution for the central compartment

326627

1.072

260011.65

169213.19

369548.19

Cl (mL/h)

Central clearance

21109.2

0.184

19214.724

16224.881

22463.998

V2 (mL)

Volume of distribution for the peripheral compartment

676758

0.232

721665.92

567400.38

835445.28

Cl2 (mL/h)

Clearance between the central and the peripheral compartment

12550.5

0.710

16958.522

11499.469

24340.243

CLmilk (mL/h)

Clearance from the central compartment to the milk

882.461

0.121

816.285

686.264

957.191

Ka (1/h)

Absorption rate constant after subcutaneous (SC) injection

0.295

6.255

0.938

0.327

2.318

Residue error 1 (%)

Proportional error model of tulathromycin concentrations in plasma

0.485

NA

0.484

0.419

0.549

Residue error 2 (%)

Proportional error model of CP-60,300 cumulative amounts in milk

0.0234

NA

0.0228

0.0157

0.0279

  1. CI confidence interval, IIV interindividual variability, NA not available